ClinVar Miner

Submissions for variant NM_000142.5(FGFR3):c.749C>T (p.Pro250Leu)

dbSNP: rs4647924
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV002233499 SCV000762845 uncertain significance not provided 2022-12-02 criteria provided, single submitter clinical testing This variant disrupts the p.Pro250 amino acid residue in FGFR3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 9042914, 10094188, 10861678, 15915095, 26740388). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt FGFR3 protein function. ClinVar contains an entry for this variant (Variation ID: 533893). This missense change has been observed in individual(s) with clinical features of FGFR3-related conditions (PMID: 12362036). This variant is present in population databases (no rsID available, gnomAD 0.004%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 250 of the FGFR3 protein (p.Pro250Leu). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
PreventionGenetics, part of Exact Sciences RCV003403475 SCV004105777 uncertain significance FGFR3-related condition 2022-10-08 criteria provided, single submitter clinical testing The FGFR3 c.749C>T variant is predicted to result in the amino acid substitution p.Pro250Leu. This variant was reported in an individual with craniosynostosis and found to be inherited from her very mildly affected mother (Schindler et al 2002. PubMed ID: 12362036). This variant is reported in 0.0041% of alleles in individuals of European (Finnish) descent in gnomAD (http://gnomad.broadinstitute.org/variant/4-1803571-C-T). A different missense variant affecting the same amino acid is a common cause of isolated craniosynostosis (see for example, Kruszka. 2016. PubMed ID: 26740388 ). Although we suspect that this variant may be pathogenic, at this time, the clinical significance is uncertain due to the absence of conclusive functional and genetic evidence.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.